Literaturverzeichnis

Aarvak, T.; Chabaud, M.; Miossec, P. und Natvig, J. B. (1999): IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells, J Immunol 162) [3], Seite 1246-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9973376

Ali, M.; Ponchel, F.; Wilson, K. E.; Francis, M. J.; Wu, X.; Verhoef, A.; Boylston, A. W.; Veale, D. J.; Emery, P.; Markham, A. F.; Lamb, J. R. und Isaacs, J. D. (2001): Rheumatoid arthritis synovial T cells regulate transcription of several genes associated with antigen-induced anergy, J Clin Invest 107) [4], Seite 519-28. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11181651

Alonzi, T.; Fattori, E.; Lazzaro, D.; Costa, P.; Probert, L.; Kollias, G.; De Benedetti, F.; Poli, V. und Ciliberto, G. (1998): Interleukin 6 is required for the development of collagen-induced arthritis, J Exp Med 187) [4], Seite 461-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9463396

Amigorena, S.; Lankar, D.; Briken, V.; Gapin, L.; Viguier, M. und Bonnerot, C. (1998): Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens, J Exp Med 187) [4], Seite 505-15. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9463401

Andersson, E. C.; Hansen, B. E.; Jacobsen, H.; Madsen, L. S.; Andersen, C. B.; Engberg, J.; Rothbard, J. B.; McDevitt, G. S.; Malmstrom, V.; Holmdahl, R.; Svejgaard, A. und Fugger, L. (1998): Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice, Proc Natl Acad Sci U S A 95) [13], Seite 7574-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9636191

Andersson, M. und Holmdahl, R. (1990): Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse, Eur J Immunol 20) [5], Seite 1061-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1694131

Bathon, J. M.; Martin, R. W.; Fleischmann, R. M.; Tesser, J. R.; Schiff, M. H.; Keystone, E. C.; Genovese, M. C.; Wasko, M. C.; Moreland, L. W.; Weaver, A. L.; Markenson, J. und Finck, B. K. (2000): A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis, N Engl J Med 343) [22], Seite 1586-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11096165

Behlke, M. A.; Chou, H. S.; Huppi, K. und Loh, D. Y. (1986): Murine T-cell receptor mutants with deletions of beta-chain variable region genes, Proc Natl Acad Sci U S A 83) [3], Seite 767-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3456168

Beutler, B. und Cerami, A. (1989): The biology of cachectin/TNF--a primary mediator of the host response, Annu Rev Immunol 7), Seite 625-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2540776

Boissier, M. C.; Feng, X. Z.; Carlioz, A.; Roudier, R. und Fournier, C. (1987): Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis, Ann Rheum Dis 46) [9], Seite 691-700. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3675011

Brahn, E. und Trentham, D. E. (1984): Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis, Cell Immunol 86) [2], Seite 421-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6610483

Brennan, F. M.; Chantry, D.; Jackson, A.; Maini, R. und Feldmann, M. (1989): Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis, Lancet 2) [8657], Seite 244-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2569055

Bresnihan, B.; Alvaro-Gracia, J. M.; Cobby, M.; Doherty, M.; Domljan, Z.; Emery, P.; Nuki, G.; Pavelka, K.; Rau, R.; Rozman, B.; Watt, I.; Williams, B.; Aitchison, R.; McCabe, D. und Musikic, P. (1998): Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist, Arthritis Rheum 41) [12], Seite 2196-204. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9870876

Brodeur, J. P.; Ruddy, S.; Schwartz, L. B. und Moxley, G. (1991): Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis, Arthritis Rheum 34) [12], Seite 1531-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1747138

Carlsen, S.; Hansson, A. S.; Olsson, H.; Heinegard, D. und Holmdahl, R. (1998): Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats, Clin Exp Immunol 114) [3], Seite 477-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9844060

Cathcart, E. S.; Hayes, K. C.; Gonnerman, W. A.; Lazzari, A. A. und Franzblau, C. (1986): Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen, Lab Invest 54) [1], Seite 26-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3941539

Cha, H. S.; Kim, T. J.; Kim, J. Y.; Lee, M. H.; Jeon, C. H.; Kim, J.; Bae, E. K.; Ahn, K. S. und Koh, E. M. (2004): Autoantibodies to glucose-6-phosphate isomerase are elevated in the synovial fluid of rheumatoid arthritis patients, Scand J Rheumatol 33) [3], Seite 179-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15228189

Chabaud, M.; Garnero, P.; Dayer, J. M.; Guerne, P. A.; Fossiez, F. und Miossec, P. (2000): Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis, Cytokine 12) [7], Seite 1092-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10880256

Chabaud, M.; Page, G. und Miossec, P. (2001): Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines, J Immunol 167) [10], Seite 6015-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11698482

Chang, Y. H.; Pearson, C. M. und Abe, C. (1980): Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: immunologic, histopathologic, and other studies, Arthritis Rheum 23) [1], Seite 62-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7352945

Chang, Y. H.; Pearson, C. M. und Chedid, L. (1981): Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan, J Exp Med 153) [4], Seite 1021-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6972989

Chaput, M.; Claes, V.; Portetelle, D.; Cludts, I.; Cravador, A.; Burny, A.; Gras, H. und Tartar, A. (1988): The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase, Nature 332) [6163], Seite 454-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3352744

Cobbold, S. P.; Martin, G. und Waldmann, H. (1990): The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies, Eur J Immunol 20) [12], Seite 2747-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1980112

Cohen, S.; Hurd, E.; Cush, J.; Schiff, M.; Weinblatt, M. E.; Moreland, L. W.; Kremer, J.; Bear, M. B.; Rich, W. J. und McCabe, D. (2002): Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial, Arthritis Rheum 46) [3], Seite 614-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11920396

Corr, M. und Crain, B. (2002): The role of FcgammaR signaling in the K/B x N serum transfer model of arthritis, J Immunol 169) [11], Seite 6604-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12444173

Corthay, A.; Johansson, A.; Vestberg, M. und Holmdahl, R. (1999): Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice, Int Immunol 11) [7], Seite 1065-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10383939

Courtenay, J. S.; Dallman, M. J.; Dayan, A. D.; Martin, A. und Mosedale, B. (1980): Immunisation against heterologous type II collagen induces arthritis in mice, Nature 283) [5748], Seite 666-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6153460

Cremer, M. A.; Ye, X. J.; Terato, K.; Griffiths, M. M.; Watson, W. C. und Kang, A. H. (1998): Immunity to type IX collagen in rodents: a study of type IX collagen for autoimmune and arthritogenic activities, Clin Exp Immunol 112) [3], Seite 375-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9649204

Despres, N.; Talbot, G.; Plouffe, B.; Boire, G. und Menard, H. A. (1995): Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera, J Clin Invest 95) [4], Seite 1891-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7706496

Dolhain, R. J.; van der Heiden, A. N.; ter Haar, N. T.; Breedveld, F. C. und Miltenburg, A. M. (1996): Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis, Arthritis Rheum 39) [12], Seite 1961-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8961900

Dorner, T.; Egerer, K.; Feist, E. und Burmester, G. R. (2004): Rheumatoid factor revisited, Curr Opin Rheumatol 16) [3], Seite 246-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15103252

Duncan, A. R. und Winter, G. (1988): The binding site for C1q on IgG, Nature 332) [6166], Seite 738-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3258649

Edwards, J. C. (1994): The nature and origins of synovium: experimental approaches to the study of synoviocyte differentiation, J Anat 184 ( Pt 3)), Seite 493-501. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7928638

Edwards, J. C.; Szczepanski, L.; Szechinski, J.; Filipowicz-Sosnowska, A.; Emery, P.; Close, D. R.; Stevens, R. M. und Shaw, T. (2004): Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis, N Engl J Med 350) [25], Seite 2572-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15201414

Elliott, M. J.; Maini, R. N.; Feldmann, M.; Kalden, J. R.; Antoni, C.; Smolen, J. S.; Leeb, B.; Breedveld, F. C.; Macfarlane, J. D.; Bijl, H. und et al. (1994): Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis, Lancet 344) [8930], Seite 1105-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7934491

Englert, M. E.; Ferguson, K. M.; Suarez, C. R.; Oronsky, A. L. und Kerwar, S. S. (1986): Passive transfer of collagen arthritis: heterogeneity of anti-collagen IgG, Cell Immunol 101) [2], Seite 373-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2428515

Erickson, R. P.; Tachibana, D. K.; Herzenberg, L. A. und Rosenberg, L. T. (1964): A Single Gene Controlling Hemolytic Complement and a Serum Antigen in the Mouse, J Immunol 92), Seite 611-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14139033

Faik, P.; Walker, J. I.; Redmill, A. A. und Morgan, M. J. (1988): Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3' sequences, Nature 332) [6163], Seite 455-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3352745

Fava, R.; Olsen, N.; Keski-Oja, J.; Moses, H. und Pincus, T. (1989): Active and latent forms of transforming growth factor beta activity in synovial effusions, J Exp Med 169) [1], Seite 291-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2909658

Feldmann, M.; Brennan, F. M. und Maini, R. N. (1996): Role of cytokines in rheumatoid arthritis, Annu Rev Immunol 14), Seite 397-440. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8717520

Firestein, G. S. (2003): Evolving concepts of rheumatoid arthritis, Nature 423) [6937], Seite 356-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12748655

Firestein, G. S.; Alvaro-Gracia, J. M. und Maki, R. (1990): Quantitative analysis of cytokine gene expression in rheumatoid arthritis, J Immunol 144) [9], Seite 3347-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2109776

Firestein, G. S. und Zvaifler, N. J. (1990): How important are T cells in chronic rheumatoid synovitis?, Arthritis Rheum 33) [6], Seite 768-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2194461

Frei, Y.; Lambris, J. D. und Stockinger, B. (1987): Generation of a monoclonal antibody to mouse C5 application in an ELISA assay for detection of anti-C5 antibodies, Mol Cell Probes 1) [2], Seite 141-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3453897

Fugger, L.; Rothbard, J. B. und Sonderstrup-McDevitt, G. (1996): Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen, Eur J Immunol 26) [4], Seite 928-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8625990

Gabriel, S. E. (2001): The epidemiology of rheumatoid arthritis, Rheum Dis Clin North Am 27) [2], Seite 269-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11396092

Glant, T. T.; Cs-Szabo, G.; Nagase, H.; Jacobs, J. J. und Mikecz, K. (1998): Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage, Arthritis Rheum 41) [6], Seite 1007-18. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9627010

Graham Solomons, J. T.; Zimmerly, E. M.; Burns, S.; Krishnamurthy, N.; Swan, M. K.; Krings, S.; Muirhead, H.; Chirgwin, J. und Davies, C. (2004): The crystal structure of mouse phosphoglucose isomerase at 1.6A resolution and its complex with glucose 6-phosphate reveals the catalytic mechanism of sugar ring opening, J Mol Biol 342) [3], Seite 847-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15342241

Gregersen, P. K.; Silver, J. und Winchester, R. J. (1987): The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis Rheum 30) [11], Seite 1205-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2446635

Gurney, M. E.; Apatoff, B. R.; Spear, G. T.; Baumel, M. J.; Antel, J. P.; Bania, M. B. und Reder, A. T. (1986): Neuroleukin: a lymphokine product of lectin-stimulated T cells, Science 234) [4776], Seite 574-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3020690

Gurney, M. E.; Heinrich, S. P.; Lee, M. R. und Yin, H. S. (1986): Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons, Science 234) [4776], Seite 566-74. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3764429

Hamano, Y.; Arase, H.; Saisho, H. und Saito, T. (2000): Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses, J Immunol 164) [12], Seite 6113-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10843660

Hassfeld, W.; Steiner, G.; Hartmuth, K.; Kolarz, G.; Scherak, O.; Graninger, W.; Thumb, N. und Smolen, J. S. (1989): Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis, Arthritis Rheum 32) [12], Seite 1515-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2597207

Hermann, E.; Fleischer, B.; Mayet, W. J.; Poralla, T. und Meyer zum Buschenfelde, K. H. (1989): Correlation of synovial fluid interleukin 6 (IL-6) activities with IgG concentrations in patients with inflammatory joint disease and osteoarthritis, Clin Exp Rheumatol 7) [4], Seite 411-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2591114

Herve, C. A.; Wait, R. und Venables, P. J. (2003): Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis, Rheumatology (Oxford) 42) [8], Seite 986-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12730513

Hietala, M. A.; Jonsson, I. M.; Tarkowski, A.; Kleinau, S. und Pekna, M. (2002): Complement deficiency ameliorates collagen-induced arthritis in mice, J Immunol 169) [1], Seite 454-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12077276

Holmdahl, R.; Bockermann, R.; Backlund, J. und Yamada, H. (2002): The molecular pathogenesis of collagen-induced arthritis in mice--a model for rheumatoid arthritis, Ageing Res Rev 1) [1], Seite 135-47. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12039453

Holmdahl, R.; Jansson, L.; Andersson, M. und Larsson, E. (1988): Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis, Immunology 65) [2], Seite 305-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3192274

Holmdahl, R.; Jansson, L.; Gullberg, D.; Rubin, K.; Forsberg, P. O. und Klareskog, L. (1985): Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II, Clin Exp Immunol 62) [3], Seite 639-46. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=4085150

Holmdahl, R.; Jansson, L.; Larsson, A. und Jonsson, R. (1990): Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies, Scand J Immunol 31) [2], Seite 147-57. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1968678

Holmdahl, R.; Jansson, L.; Larsson, E.; Rubin, K. und Klareskog, L. (1986): Homologous type II collagen induces chronic and progressive arthritis in mice, Arthritis Rheum 29) [1], Seite 106-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3947407

Holmdahl, R.; Klareskog, L.; Rubin, K.; Larsson, E. und Wigzell, H. (1985): T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones, Scand J Immunol 22) [3], Seite 295-306. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2413528

Hom, J. T.; Butler, L. D.; Riedl, P. E. und Bendele, A. M. (1988): The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities, Eur J Immunol 18) [6], Seite 881-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3260183

Homann, D. und von Herrath, M. (2004): Regulatory T cells and type 1 diabetes, Clin Immunol 112) [3], Seite 202-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15308110

Ishikawa, H.; Smiley, J. D. und Ziff, M. (1975): Electron microscopic demonstration of immunoglobulin deposition in rheumatoid cartilage, Arthritis Rheum 18) [6], Seite 563-76. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=54168

Ito, A.; Itoh, Y.; Sasaguri, Y.; Morimatsu, M. und Mori, Y. (1992): Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts, Arthritis Rheum 35) [10], Seite 1197-201. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1418006

Ji, H.; Gauguier, D.; Ohmura, K.; Gonzalez, A.; Duchatelle, V.; Danoy, P.; Garchon, H. J.; Degott, C.; Lathrop, M.; Benoist, C. und Mathis, D. (2001): Genetic influences on the end-stage effector phase of arthritis, J Exp Med 194) [3], Seite 321-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11489951

Ji, H.; Ohmura, K.; Mahmood, U.; Lee, D. M.; Hofhuis, F. M.; Boackle, S. A.; Takahashi, K.; Holers, V. M.; Walport, M.; Gerard, C.; Ezekowitz, A.; Carroll, M. C.; Brenner, M.; Weissleder, R.; Verbeek, J. S.; Duchatelle, V.; Degott, C.; Benoist, C. und Mathis, D. (2002): Arthritis critically dependent on innate immune system players, Immunity 16) [2], Seite 157-68. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11869678

Ji, H.; Pettit, A.; Ohmura, K.; Ortiz-Lopez, A.; Duchatelle, V.; Degott, C.; Gravallese, E.; Mathis, D. und Benoist, C. (2002): Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis, J Exp Med 196) [1], Seite 77-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12093872

Jose, P. J.; Moss, I. K.; Maini, R. N. und Williams, T. J. (1990): Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase, Ann Rheum Dis 49) [10], Seite 747-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2241262

Jouen, F.; Vittecoq, O.; Leguillou, F.; Tabti-Titon, I.; Menard, J. F.; Mejjad, O.; Pouplin, S.; Boumier, P.; Fardellone, P.; Gayet, A.; Gilbert, D.; Tron, F. und Le Loet, X. (2004): Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis, Clin Exp Immunol 137) [3], Seite 606-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15320914

Kassahn, D.; Kolb, C.; Solomon, S.; Bochtler, P. und Illges, H. (2002): Few human autoimmune sera detect GPI, Nat Immunol 3) [5], Seite 411-2; author reply 412-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11976712

Katsikis, P. D.; Chu, C. Q.; Brennan, F. M.; Maini, R. N. und Feldmann, M. (1994): Immunoregulatory role of interleukin 10 in rheumatoid arthritis, J Exp Med 179) [5], Seite 1517-27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8163935

Keffer, J.; Probert, L.; Cazlaris, H.; Georgopoulos, S.; Kaslaris, E.; Kioussis, D. und Kollias, G. (1991): Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis, Embo J 10) [13], Seite 4025-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1721867

Kjellen, P.; Brunsberg, U.; Broddefalk, J.; Hansen, B.; Vestberg, M.; Ivarsson, I.; Engstrom, A.; Svejgaard, A.; Kihlberg, J.; Fugger, L. und Holmdahl, R. (1998): The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules, Eur J Immunol 28) [2], Seite 755-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9521085

Klaus, G. G.; Pepys, M. B.; Kitajima, K. und Askonas, B. A. (1979): Activation of mouse complement by different classes of mouse antibody, Immunology 38) [4], Seite 687-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=521057

Kleinau, S.; Martinsson, P. und Heyman, B. (2000): Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors, J Exp Med 191) [9], Seite 1611-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10790435

Klippel, J. H. und Dieppe, P. A. (1998): Rheumatology, 2nd. Auflage, Mosby International, London.

Koch, A. E.; Burrows, J. C.; Haines, G. K.; Carlos, T. M.; Harlan, J. M. und Leibovich, S. J. (1991): Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues, Lab Invest 64) [3], Seite 313-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1706003

Kohashi, O.; Aihara, K.; Ozawa, A.; Kotani, S. und Azuma, I. (1982): New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats, Lab Invest 47) [1], Seite 27-36. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7087395

Korganow, A. S.; Ji, H.; Mangialaio, S.; Duchatelle, V.; Pelanda, R.; Martin, T.; Degott, C.; Kikutani, H.; Rajewsky, K.; Pasquali, J. L.; Benoist, C. und Mathis, D. (1999): From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins, Immunity 10) [4], Seite 451-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10229188

Kotake, S.; Sato, K.; Kim, K. J.; Takahashi, N.; Udagawa, N.; Nakamura, I.; Yamaguchi, A.; Kishimoto, T.; Suda, T. und Kashiwazaki, S. (1996): Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation, J Bone Miner Res 11) [1], Seite 88-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8770701

Kouskoff, V.; Korganow, A. S.; Duchatelle, V.; Degott, C.; Benoist, C. und Mathis, D. (1996): Organ-specific disease provoked by systemic autoimmunity, Cell 87) [5], Seite 811-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8945509

Kremer, J. M.; Westhovens, R.; Leon, M.; Di Giorgio, E.; Alten, R.; Steinfeld, S.; Russell, A.; Dougados, M.; Emery, P.; Nuamah, I. F.; Williams, G. R.; Becker, J. C.; Hagerty, D. T. und Moreland, L. W. (2003): Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig, N Engl J Med 349) [20], Seite 1907-15. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14614165

Krenn, V.; Morawietz, L.; Haupl, T.; Neidel, J.; Petersen, I. und Konig, A. (2002): Grading of chronic synovitis--a histopathological grading system for molecular and diagnostic pathology, Pathol Res Pract 198) [5], Seite 317-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12092767

Kyburz, D.; Carson, D. A. und Corr, M. (2000): The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis, Arthritis Rheum 43) [11], Seite 2571-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11083282

Lee, D. M.; Friend, D. S.; Gurish, M. F.; Benoist, C.; Mathis, D. und Brenner, M. B. (2002): Mast cells: a cellular link between autoantibodies and inflammatory arthritis, Science 297) [5587], Seite 1689-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12215644

Lee, Y. H.; Choi, S. J.; Ji, J. D. und Song, G. G. (2000): Serum creatine kinase in patients with rheumatic diseases, Clin Rheumatol 19) [4], Seite 296-300. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10941812

Lipsky, P. E.; van der Heijde, D. M.; St Clair, E. W.; Furst, D. E.; Breedveld, F. C.; Kalden, J. R.; Smolen, J. S.; Weisman, M.; Emery, P.; Feldmann, M.; Harriman, G. R. und Maini, R. N. (2000): Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group, N Engl J Med 343) [22], Seite 1594-602. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11096166

Maccioni, M.; Zeder-Lutz, G.; Huang, H.; Ebel, C.; Gerber, P.; Hergueux, J.; Marchal, P.; Duchatelle, V.; Degott, C.; van Regenmortel, M.; Benoist, C. und Mathis, D. (2002): Arthritogenic monoclonal antibodies from K/BxN mice, J Exp Med 195) [8], Seite 1071-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11956298

Maddison, P. J.; Isenberg, D; Woo, P; Glass, D. N. und Breedveld, F. C. (2004): Oxford Textbook of Rheumatology, 3rd ed.. Auflage, Oxford University Press, 0-19-850948-0.

Maini, R. N.; Breedveld, F. C.; Kalden, J. R.; Smolen, J. S.; Davis, D.; Macfarlane, J. D.; Antoni, C.; Leeb, B.; Elliott, M. J.; Woody, J. N.; Schaible, T. F. und Feldmann, M. (1998): Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis, Arthritis Rheum 41) [9], Seite 1552-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9751087

Malmstrom, V.; Backlund, J.; Jansson, L.; Kihlberg, J. und Holmdahl, R. (2000): T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis, Arthritis Res 2) [4], Seite 315-26. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11056672

Malmstrom, V.; Michaelsson, E.; Burkhardt, H.; Mattsson, R.; Vuorio, E. und Holmdahl, R. (1996): Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis, Proc Natl Acad Sci U S A 93) [9], Seite 4480-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8633094

Mangialaio, S.; Ji, H.; Korganow, A. S.; Kouskoff, V.; Benoist, C. und Mathis, D. (1999): The arthritogenic T cell receptor and its ligand in a model of spontaneous arthritis, Arthritis Rheum 42) [12], Seite 2517-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10615996

Martin, B.; Banz, A.; Bienvenu, B.; Cordier, C.; Dautigny, N.; Becourt, C. und Lucas, B. (2004): Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo, J Immunol 172) [6], Seite 3391-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15004137

Matsumoto, I.; Lee, D. M.; Goldbach-Mansky, R.; Sumida, T.; Hitchon, C. A.; Schur, P. H.; Anderson, R. J.; Coblyn, J. S.; Weinblatt, M. E.; Brenner, M.; Duclos, B.; Pasquali, J. L.; El-Gabalawy, H.; Mathis, D. und Benoist, C. (2003): Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders, Arthritis Rheum 48) [4], Seite 944-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12687536

Matsumoto, I.; Maccioni, M.; Lee, D. M.; Maurice, M.; Simmons, B.; Brenner, M.; Mathis, D. und Benoist, C. (2002): How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease, Nat Immunol 3) [4], Seite 360-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11896391

Matsumoto, I.; Staub, A.; Benoist, C. und Mathis, D. (1999): Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme, Science 286) [5445], Seite 1732-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10576739

Maurice, M. M.; Nakamura, H.; van der Voort, E. A.; van Vliet, A. I.; Staal, F. J.; Tak, P. P.; Breedveld, F. C. und Verweij, C. L. (1997): Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis, J Immunol 158) [3], Seite 1458-65. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9013992

Michaelsson, E.; Andersson, M.; Engstrom, A. und Holmdahl, R. (1992): Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection, Eur J Immunol 22) [7], Seite 1819-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1378019

Moreland, L. W.; Alten, R.; Van den Bosch, F.; Appelboom, T.; Leon, M.; Emery, P.; Cohen, S.; Luggen, M.; Shergy, W.; Nuamah, I. und Becker, J. C. (2002): Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion, Arthritis Rheum 46) [6], Seite 1470-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12115176

Morgan, B. P.; Daniels, R. H. und Williams, B. D. (1988): Measurement of terminal complement complexes in rheumatoid arthritis, Clin Exp Immunol 73) [3], Seite 473-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3208454

Morgan, K.; Clague, R. B.; Shaw, M. J.; Firth, S. A.; Twose, T. M. und Holt, P. J. (1981): Native type II collagen--induced arthritis in the rat: the effect of complement depletion by cobra venom factor, Arthritis Rheum 24) [11], Seite 1356-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7317113

Morgan, M. E.; Sutmuller, R. P.; Witteveen, H. J.; van Duivenvoorde, L. M.; Zanelli, E.; Melief, C. J.; Snijders, A.; Offringa, R.; de Vries, R. R. und Toes, R. E. (2003): CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis, Arthritis Rheum 48) [5], Seite 1452-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12746920

Morita, Y.; Yamamura, M.; Kawashima, M.; Harada, S.; Tsuji, K.; Shibuya, K.; Maruyama, K. und Makino, H. (1998): Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis, Arthritis Rheum 41) [9], Seite 1669-76. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9751101

Muraki, Y.; Matsumoto, I.; Chino, Y.; Hayashi, T.; Suzuki, E.; Goto, D.; Ito, S.; Murata, H.; Tsutsumi, A. und Sumida, T. (2004): Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies: possible mechanism of autoantibody production, Biochem Biophys Res Commun 323) [2], Seite 518-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15369782

Myers, L. K.; Brand, D. D.; Ye, X. J.; Cremer, M. A.; Rosloniec, E. F.; Bodo, M.; Myllyharju, J.; Helaakoski, T.; Nokelainen, M.; Pihlajaniemi, T.; Kivirikko, K.; Yang, C. L.; Ala-Kokko, L.; Prockop, D. J.; Notbohm, H.; Fietzek, P.; Stuart, J. M. und Kang, A. H. (1998): Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice, Immunology 95) [4], Seite 631-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9893056

Myers, L. K.; Miyahara, H.; Terato, K.; Seyer, J. M.; Stuart, J. M. und Kang, A. H. (1995): Collagen-induced arthritis in B10.RIII mice (H-2r): identification of an arthritogenic T-cell determinant, Immunology 84) [4], Seite 509-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7540590

Nakae, S.; Nambu, A.; Sudo, K. und Iwakura, Y. (2003): Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice, J Immunol 171) [11], Seite 6173-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14634133

Neumann, E.; Barnum, S. R.; Tarner, I. H.; Echols, J.; Fleck, M.; Judex, M.; Kullmann, F.; Mountz, J. D.; Scholmerich, J.; Gay, S. und Muller-Ladner, U. (2002): Local production of complement proteins in rheumatoid arthritis synovium, Arthritis Rheum 46) [4], Seite 934-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11953970

Nordling, C.; Karlsson-Parra, A.; Jansson, L.; Holmdahl, R. und Klareskog, L. (1992): Characterization of a spontaneously occurring arthritis in male DBA/1 mice, Arthritis Rheum 35) [6], Seite 717-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1318050

Ohshima, S.; Saeki, Y.; Mima, T.; Sasai, M.; Nishioka, K.; Nomura, S.; Kopf, M.; Katada, Y.; Tanaka, T.; Suemura, M. und Kishimoto, T. (1998): Interleukin 6 plays a key role in the development of antigen-induced arthritis, Proc Natl Acad Sci U S A 95) [14], Seite 8222-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9653168

Okamoto, H.; Yamamura, M.; Morita, Y.; Harada, S.; Makino, H. und Ota, Z. (1997): The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis, Arthritis Rheum 40) [6], Seite 1096-105. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9182920

Olsen, N. J. und Stein, C. M. (2004): New drugs for rheumatoid arthritis, N Engl J Med 350) [21], Seite 2167-79. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15152062

Pearson, C. M. (1956): Development of arthritis, periarthritis and periostitis in rats given adjuvants, Proc Soc Exp Biol Med 91) [1], Seite 95-101. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=13297719

Piguet, P. F.; Grau, G. E.; Vesin, C.; Loetscher, H.; Gentz, R. und Lesslauer, W. (1992): Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor, Immunology 77) [4], Seite 510-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1337334

Pincus, T.; Brooks, R. H. und Callahan, L. F. (1994): Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures, Ann Intern Med 120) [1], Seite 26-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8250453

Ranges, G. E.; Sriram, S. und Cooper, S. M. (1985): Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4, J Exp Med 162) [3], Seite 1105-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3928802

Reife, R. A.; Loutis, N.; Watson, W. C.; Hasty, K. A. und Stuart, J. M. (1991): SWR mice are resistant to collagen-induced arthritis but produce potentially arthritogenic antibodies, Arthritis Rheum 34) [6], Seite 776-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2053925

Roodman, G. D. (1992): Interleukin-6: an osteotropic factor?, J Bone Miner Res 7) [5], Seite 475-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1615755

Rosloniec, E. F.; Brand, D. D.; Myers, L. K.; Esaki, Y.; Whittington, K. B.; Zaller, D. M.; Woods, A.; Stuart, J. M. und Kang, A. H. (1998): Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen, J Immunol 160) [6], Seite 2573-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9510154

Rosloniec, E. F.; Brand, D. D.; Myers, L. K.; Whittington, K. B.; Gumanovskaya, M.; Zaller, D. M.; Woods, A.; Altmann, D. M.; Stuart, J. M. und Kang, A. H. (1997): An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen, J Exp Med 185) [6], Seite 1113-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9091584

Rosloniec, E. F.; Whittington, K. B.; Brand, D. D.; Myers, L. K. und Stuart, J. M. (1996): Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis, Cell Immunol 172) [1], Seite 21-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8806802

Sakaguchi, N.; Takahashi, T.; Hata, H.; Nomura, T.; Tagami, T.; Yamazaki, S.; Sakihama, T.; Matsutani, T.; Negishi, I.; Nakatsuru, S. und Sakaguchi, S. (2003): Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice, Nature 426) [6965], Seite 454-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14647385

Sakaguchi, S.; Sakaguchi, N.; Asano, M.; Itoh, M. und Toda, M. (1995): Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J Immunol 155) [3], Seite 1151-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7636184

Sanmarti, R.; Collado, A.; Gratacos, J.; Herrera, B. E.; Font, J.; Canete, J. D.; Orellana, C. und Munoz-Gomez, J. (1996): Reduced serum creatine kinase activity in inflammatory rheumatic diseases, J Rheumatol 23) [2], Seite 310-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8882037

Sasai, M.; Saeki, Y.; Ohshima, S.; Nishioka, K.; Mima, T.; Tanaka, T.; Katada, Y.; Yoshizaki, K.; Suemura, M. und Kishimoto, T. (1999): Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice, Arthritis Rheum 42) [8], Seite 1635-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10446862

Schaller, M.; Burton, D. R. und Ditzel, H. J. (2001): Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease, Nat Immunol 2) [8], Seite 746-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11477412

Schepp, C. P.; Dannecker, L.; Haug, M.; Kummerle-Deschner, J.; Beck, H.; Kotter, I.; Holzer, U. und Dannecker, G. E. (2004): Autoantibodies in juvenile idiopathic arthritis: glucose-6-phosphate isomerase is not a specific target, J Rheumatol 31) [8], Seite 1630-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15290745

Schmitt, A.; Schubert, D.; Sengler, C. und Kamradt, T. (2004): Autoantibodies against glucose-6-phosphate isomerase are not a diagnostic marker for juvenile idiopathic arthritis, Ann Rheum Dis 63) [4], Seite 463. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15020348

Shaw, M. H.; Boyartchuk, V.; Wong, S.; Karaghiosoff, M.; Ragimbeau, J.; Pellegrini, S.; Muller, M.; Dietrich, W. F. und Yap, G. S. (2003): A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity, Proc Natl Acad Sci U S A 100) [20], Seite 11594-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14500783

Shimizu, K.; Tani, M.; Watanabe, H.; Nagamachi, Y.; Niinaka, Y.; Shiroishi, T.; Ohwada, S.; Raz, A. und Yokota, J. (1999): The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein, FEBS Lett 456) [2], Seite 295-300. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10456327

Shouda, T.; Yoshida, T.; Hanada, T.; Wakioka, T.; Oishi, M.; Miyoshi, K.; Komiya, S.; Kosai, K.; Hanakawa, Y.; Hashimoto, K.; Nagata, K. und Yoshimura, A. (2001): Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis, J Clin Invest 108) [12], Seite 1781-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11748261

Smolen, J. S. und Steiner, G. (1998): Are autoantibodies active players or epiphenomena?, Curr Opin Rheumatol 10) [3], Seite 201-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9608322

Smolen, J. S. und Steiner, G. (2003): Therapeutic strategies for rheumatoid arthritis, Nat Rev Drug Discov 2) [6], Seite 473-88. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12776222

Solomon, S. (2003): Role of pathogenic auto-antibodies and innate immunity mediators in K/BxN murine model for rheumatoid arthritis, Universität Konstanz.

Steiner, G.; Hartmuth, K.; Skriner, K.; Maurer-Fogy, I.; Sinski, A.; Thalmann, E.; Hassfeld, W.; Barta, A. und Smolen, J. S. (1992): Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex, J Clin Invest 90) [3], Seite 1061-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1522214

Steiner, G.; Tohidast-Akrad, M.; Witzmann, G.; Vesely, M.; Studnicka-Benke, A.; Gal, A.; Kunaver, M.; Zenz, P. und Smolen, J. S. (1999): Cytokine production by synovial T cells in rheumatoid arthritis, Rheumatology (Oxford) 38) [3], Seite 202-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10325658

Stuart, J. M.; Cremer, M. A.; Townes, A. S. und Kang, A. H. (1982): Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis, J Exp Med 155) [1], Seite 1-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7054355

Svendsen, P.; Andersen, C. B.; Willcox, N.; Coyle, A. J.; Holmdahl, R.; Kamradt, T. und Fugger, L. (2004): Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice, J Immunol 173) [11], Seite 7037-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15557201

Tada, Y.; Ho, A.; Koh, D. R. und Mak, T. W. (1996): Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis, J Immunol 156) [11], Seite 4520-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8666829

Tak, P. P.; Thurkow, E. W.; Daha, M. R.; Kluin, P. M.; Smeets, T. J.; Meinders, A. E. und Breedveld, F. C. (1995): Expression of adhesion molecules in early rheumatoid synovial tissue, Clin Immunol Immunopathol 77) [3], Seite 236-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7586733

Terato, K.; Hasty, K. A.; Reife, R. A.; Cremer, M. A.; Kang, A. H. und Stuart, J. M. (1992): Induction of arthritis with monoclonal antibodies to collagen, J Immunol 148) [7], Seite 2103-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1545120

Thorbecke, G. J.; Shah, R.; Leu, C. H.; Kuruvilla, A. P.; Hardison, A. M. und Palladino, M. A. (1992): Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice, Proc Natl Acad Sci U S A 89) [16], Seite 7375-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1502148

Trentham, D. E.; Dynesius, R. A. und David, J. R. (1978): Passive transfer by cells of type II collagen-induced arthritis in rats, J Clin Invest 62) [2], Seite 359-66. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=27533

Trentham, D. E.; Townes, A. S. und Kang, A. H. (1977): Autoimmunity to type II collagen an experimental model of arthritis, J Exp Med 146) [3], Seite 857-68. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=894190

Tsutsumi, S.; Gupta, S. K.; Hogan, V.; Collard, J. G. und Raz, A. (2002): Activation of small GTPase Rho is required for autocrine motility factor signaling, Cancer Res 62) [15], Seite 4484-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12154059

van Boekel, M. A.; Vossenaar, E. R.; van den Hoogen, F. H. und van Venrooij, W. J. (2002): Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value, Arthritis Res 4) [2], Seite 87-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11879544

Van Damme, J.; Opdenakker, G.; Simpson, R. J.; Rubira, M. R.; Cayphas, S.; Vink, A.; Billiau, A. und Van Snick, J. (1987): Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor, J Exp Med 165) [3], Seite 914-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3493322

van den Berg, W. B.; van de Putte, L. B.; Zwarts, W. A. und Joosten, L. A. (1984): Electrical charge of the antigen determines intraarticular antigen handling and chronicity of arthritis in mice, J Clin Invest 74) [5], Seite 1850-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6501574

van der Lubbe, P. A.; Dijkmans, B. A.; Markusse, H. M.; Nassander, U. und Breedveld, F. C. (1995): A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis, Arthritis Rheum 38) [8], Seite 1097-106. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7639806

van Gaalen, F. A.; Toes, R. E.; Ditzel, H. J.; Schaller, M.; Breedveld, F. C.; Verweij, C. L. und Huizinga, T. W. (2004): Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis, Arthritis Rheum 50) [2], Seite 395-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14872481

Vassalli, P. (1992): The pathophysiology of tumor necrosis factors, Annu Rev Immunol 10), Seite 411-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1590993

Verheijden, G. F.; Rijnders, A. W.; Bos, E.; Coenen-de Roo, C. J.; van Staveren, C. J.; Miltenburg, A. M.; Meijerink, J. H.; Elewaut, D.; de Keyser, F.; Veys, E. und Boots, A. M. (1997): Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis, Arthritis Rheum 40) [6], Seite 1115-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9182922

Verwilghen, J.; Vertessen, S.; Stevens, E. A.; Dequeker, J. und Ceuppens, J. L. (1990): Depressed T-cell reactivity to recall antigens in rheumatoid arthritis, J Clin Immunol 10) [2], Seite 90-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1970986

Wahl, S. M. (1994): Transforming growth factor beta: the good, the bad, and the ugly, J Exp Med 180) [5], Seite 1587-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7964446

Wang, Y.; Kristan, J.; Hao, L.; Lenkoski, C. S.; Shen, Y. und Matis, L. A. (2000): A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis, J Immunol 164) [8], Seite 4340-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10754334

Wang, Y.; Rollins, S. A.; Madri, J. A. und Matis, L. A. (1995): Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease, Proc Natl Acad Sci U S A 92) [19], Seite 8955-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7568051

Ward, P. A. und Zvaifler, N. J. (1971): Complement-derived leukotactic factors in inflammatory synovial fluids of humans, J Clin Invest 50) [3], Seite 606-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=5545123

Watanabe, H.; Carmi, P.; Hogan, V.; Raz, T.; Silletti, S.; Nabi, I. R. und Raz, A. (1991): Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor, J Biol Chem 266) [20], Seite 13442-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1649192

Watanabe, H.; Takehana, K.; Date, M.; Shinozaki, T. und Raz, A. (1996): Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide, Cancer Res 56) [13], Seite 2960-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8674049

Watson, W. C.; Brown, P. S.; Pitcock, J. A. und Townes, A. S. (1987): Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis, Arthritis Rheum 30) [4], Seite 460-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3580014

Watson, W. C. und Townes, A. S. (1985): Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci, J Exp Med 162) [6], Seite 1878-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3934318

Weyand, C. M.; Hicok, K. C.; Conn, D. L. und Goronzy, J. J. (1992): The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis, Ann Intern Med 117) [10], Seite 801-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1416553

Williams, R. O.; Feldmann, M. und Maini, R. N. (1992): Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis, Proc Natl Acad Sci U S A 89) [20], Seite 9784-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1409699

Williams, R. O. und Whyte, A. (1996): Anti-CD4 monoclonal antibodies suppress murine collagen-induced arthritis only at the time of primary immunisation, Cell Immunol 170) [2], Seite 291-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8660829

Wipke, B. T. und Allen, P. M. (2001): Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis, J Immunol 167) [3], Seite 1601-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11466382

Wipke, B. T.; Wang, Z.; Kim, J.; McCarthy, T. J. und Allen, P. M. (2002): Dynamic visualization of a joint-specific autoimmune response through positron emission tomography, Nat Immunol 3) [4], Seite 366-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11896393

Wolfe, F. und Hawley, D. J. (1998): The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients, J Rheumatol 25) [11], Seite 2108-17. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9818651

Wooley, P. H.; Dutcher, J.; Widmer, M. B. und Gillis, S. (1993): Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice, J Immunol 151) [11], Seite 6602-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8245488

Wooley, P. H.; Luthra, H. S.; Stuart, J. M. und David, C. S. (1981): Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates, J Exp Med 154) [3], Seite 688-700. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6792316

Wooley, P. H.; Seibold, J. R.; Whalen, J. D. und Chapdelaine, J. M. (1989): Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease, Arthritis Rheum 32) [8], Seite 1022-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2765002

Xu, W.; Seiter, K.; Feldman, E.; Ahmed, T. und Chiao, J. W. (1996): The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase, Blood 87) [11], Seite 4502-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8639816

Yuasa, T.; Kubo, S.; Yoshino, T.; Ujike, A.; Matsumura, K.; Ono, M.; Ravetch, J. V. und Takai, T. (1999): Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis, J Exp Med 189) [1], Seite 187-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9874575

Ziolkowska, M.; Koc, A.; Luszczykiewicz, G.; Ksiezopolska-Pietrzak, K.; Klimczak, E.; Chwalinska-Sadowska, H. und Maslinski, W. (2000): High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism, J Immunol 164) [5], Seite 2832-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10679127